微血管血栓和肝纤维化进展:机制和临床应用
Carlo Airola1, Maria Pallozzi1, Lucia Cerrito1
1Hepatology Unit, CEMAD Centro Malattie dell'Apparato Digerente, Medicina Interna e Gastroenterologia, Fondazione Policlinico Universitario Gemelli IRCCS, 00168 Rome, Italy.
Cells
|July 14, 2023
概括
微血管血栓,而不是出血,驱动肝纤维化进展. 凝血因子预测肝病的严重程度和死亡率,这表明肝纤维化的新治疗点.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 血液学 血液学 血液学
- 病理学 病理学 病理学
背景情况:
- 纤维化是慢性肝病的关键特征,源于慢性炎症和细胞外基质沉积.
- 慢性肝病中的凝血系统变化不会增加出血风险,但可能会促进纤维化.
- 微血管血栓症越来越被认为是肝脏纤维化的一个驱动因素.
研究的目的:
- 审查微血管血栓在肝病进展中的作用.
- 为了探索血液静止和肝纤维化之间的联系.
- 分析凝血产品作为生物标志物,并评估抗血栓治疗.
主要方法:
- 文献综述侧重于微血管血栓,血液静止和肝纤维化.
- 对将凝血与纤维生成联系起来的分子和细胞机制的分析.
- 对凝血生物标志物和抗血栓治疗的临床数据的评估.
主要成果:
- 凝血失衡,特别是微血管血栓形成,与促进肝纤维化有关.
- 凝血产品作为预测和预后生物标志物用于肝脏衰竭和死亡率.
- 目前正在评估抗血小板和抗凝固药物治疗预防纤维化进展的证据.
结论:
- 微血管血栓症在肝病的进展中起着重要作用.
- 凝血通路是理解和治疗肝纤维化的关键目标.
- 需要进一步的研究来确定抗血栓治疗在肝脏疾病管理中的有效性.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
763
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
763
Venous Thrombosis I: Introduction
13
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
13
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Clot Retraction and Fibrinolysis
6.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.5K


